Infosys, Persistent Systems and Mphasis are likely to trade with a favourable bias as a key momentum indicator - the MACD has turned positive on the technical charts for these 3 IT stocks.
IT company Mphasis on Friday said its net profit grew by 13.6 per cent to Rs 446.5 crore in January-March quarter of FY25, driven by higher margins and increased revenue from the BFSI segment. The company had reported a net profit of Rs 393.21 crore in the same period a year ago, Mphasis said in a regulatory filing. "We are pleased with a quarter of broad-based performance, reporting the highest quarter-on-quarter (QoQ) growth in 12 quarters, highest TCV (total contract value) wins in 7 quarters, highest ever quarterly and full year EPS, and 86 per cent YoY growth in pipeline. In this uncertain macro environment, our focus is on continued investments in growth, keeping tech and AI at the core, and leveraging solutions to transform and modernize our client's technology and operations stack," Nitin Rakesh, Chief Executive Officer and Managing Director, Mphasis, said in a statement. The consolidated revenue from operations of Mphasis grew by 8.7 per cent to Rs 3,710 crore during the ..
The Nifty IT index plunged amid recession-related fears due to US imposing 'reciprocal tariffs' on trading partners without showing signs of backing down
The downturn in IT stocks can be attributed to fears around recession and as manufacturing hubs in China and Taiwan face new tariffs above 30 per cent
At 9:57 AM, the Nifty IT index was trading lower by 2.30 per cent, at 39,612. It touched an intra-day low of 39,465.75 during the session so far.
The company's consolidated net profit grew nearly 15 per cent to Rs 428 crore ($49.54 million) for the quarter ended Dec. 31 compared with analysts' expectations of Rs 426 crore
In Q2, Mphasis, the midcap information technology company, reported a net profit of Rs 423.3 crore for the second quarter of the financial year (Q2 FY25), growing 8 per cent year-on-year (Y-o-Y)
Union Bank stock futures plunged nearly 8% on the back of 54% increase in OI. On the other hand, Dr. Lal Path Labs and Metropolis Health witnessed long build-up on Monday; shows derivatives data.
The northward move in Mphasis share price came after New York-based financial services company Jefferies initiated coverage with 'Buy' for a target price of Rs 3,460 per share
By 11:11 AM, the Nifty IT index had come off its peak but was still trading 0.82 per cent higher at 45,199.40. In comparison, the broader Nifty50 index was up a modest 0.11 per cent at 24,646.30
Shares of Mphasis rose 2.54 per cent at Rs 68.95 per share on the BSE in Friday's intraday deals
The developments come at a time when the markets are already grappling with geopolitical developments in West Asia and the uncertainty surrounding the outcome of the US presidential polls
The rise in Mphasis share price came after the company reported a healthy September quarter (Q2FY25) results.
Derivatives market update for Sept 19: Options data hint that short term support for Nifty is at 25,250; while upside momentum is expected above 25,500, says Sahaj Agarwal of Kotak Securities.
On the bourses, Mphasis has rallied 26.7 per cent in the last three months, driven by expectations of interest rate cuts in the US and early signs of recovery in the US-BFS sector.
The revenue growth increased by 4.6 per cent on a year-on-year basis to Rs 3,422.5 crore
Continues to be the largest shareholder
Mphasis share price: While the buyers and sellers could not be ascertained, reports said BCP Topco, an affiliate firm of BlackStone, was the likely seller
Stocks to Watch today, June 10: Reports suggest BCP Topco IX Pte, an affiliate firm of Blackstone Group, will likely sell up to 15 per cent stake in Mphasis via block deals on Monday
Mphasis specialises in cloud and cognitive services and is based in Bengaluru. It has recently launched a dedicated AI Business unit